688314 康拓医疗
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)11.59014.45913.35914.46321.829
总资产报酬率 ROA (%)9.97512.42411.49312.49418.876
投入资产回报率 ROIC (%)10.76313.39812.37813.49120.377

边际利润分析
销售毛利率 (%)78.69379.97881.18381.47382.620
营业利润率 (%)33.83932.83633.24535.97940.614
息税前利润/营业总收入 (%)35.62732.13732.12235.25544.021
净利润/营业总收入 (%)30.23127.22127.07930.90638.195

收益指标分析
经营活动净收益/利润总额(%)105.349104.831105.57896.51186.656
价值变动净收益/利润总额(%)-10.821-11.877-2.0323.9042.262
营业外收支净额/利润总额(%)5.3030.2730.3492.4119.506

偿债能力分析
流动比率 (X)4.8624.4505.3534.6146.110
速动比率 (X)4.5064.1864.9094.1715.486
资产负债率 (%)12.71814.63813.35915.12612.554
带息债务/全部投入资本 (%)4.8225.3725.3746.1453.732
股东权益/带息债务 (%)1,935.3091,720.0201,729.7301,502.6422,527.007
股东权益/负债合计 (%)684.250581.101650.424562.775699.209
利息保障倍数 (X)-331.389-40.744-25.925-21.854-51.197

营运能力分析
应收账款周转天数 (天)7.9638.51712.69011.9228.370
存货周转天数 (天)140.517167.884258.141312.673364.201